Harvard Medicine research on cystic fibrosis

Research Matters
Harvard Health Publications
Science in the News

Cystic Fibrosis Foundation

International Association of Cystic Fibrosis Adults (IACFA)

March of Dimes

Patient Referral
HMS Family Health Guide

Your rights as a research participant
Harvard Clinical Research Institute (HCRI)
Harvard Clinical Research Network (CRNet)
National Institutes of Health Database

Download

Harvard Medicine Home

Focus Articles | Back to Cystic Fibrosis

2002

Gene Switch Bumps Up Bug's Drug Resistance - May 3, 2002.
Pheontoypic switching may explain deadly infection with cystic fbrosis.

2001

Bacterium Wields Same Weapon Against Humans, Fungi - July 12, 2001.
The same traits that allow bacteria to cause disease in humans enable bacteria to kill fungal cells. In people with compromised immune systems, both P. aeruginosa and C. albicans bacteria can cause dangerous infections.

New Center Wields Genome Data to Battle Bugs - September 15, 2000.
New Center for Genomic Applications and Therapeutics (CGAT) first mission is to "apply state-of-the-art technology in genetics, chemistry, and immunology to develop therapeutic approaches toward the complete eradication of pseudomonas aeruginosa as a pathogen of patients with cystic fibrosis.

The Texture of Life - and Death - in a Hospital Community - March 24, 2000.
Second year medical student writes of patients struggles with lung disease.